Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs. / Sitges, M.; Sanchez-Tafolla, B. M.; Chiu, L. M.; Aldana, B. I.; Guarneros, A.
In: Epilepsy Research, Vol. 96, No. 3, 10.2011, p. 257-266.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs
AU - Sitges, M.
AU - Sanchez-Tafolla, B. M.
AU - Chiu, L. M.
AU - Aldana, B. I.
AU - Guarneros, A.
N1 - Funding Information: This work was financially supported by Psicofarma S.A. de C.V. and by project P-48695 from SEP-CONACYT . Berardo M. Sanchez-Tafolla scholarship was supported by grant 225708 from PAPIIT .
PY - 2011/10
Y1 - 2011/10
N2 - 4-Aminopyridine (4-AP) is a convulsing agent that in vivo preferentially releases Glu, the most important excitatory amino acid neurotransmitter in the brain. Here the ionic dependence of 4-AP-induced Glu release and the effects of several of the most common antiepileptic drugs (AEDs) and of the new potential AED, vinpocetine on 4-AP-induced Glu release were characterized in hippocampus isolated nerve endings pre-loaded with labelled Glu ([ 3H]Glu). 4-AP-induced [ 3H]Glu release was composed by a tetrodotoxin (TTX) sensitive and external Ca 2+ dependent fraction and a TTX insensitive fraction that was sensitive to the excitatory amino acid transporter inhibitor, TBOA. The AEDs: carbamazepine, phenytoin, lamotrigine and oxcarbazepine at the highest dose tested only reduced [ 3H]Glu release to 4-AP between 50-60%, and topiramate was ineffective. Vinpocetine at a much lower concentration than the above AEDs, abolished [ 3H]Glu release to 4-AP. We conclude that the decrease in [ 3H]Glu release linked to the direct blockade of presynaptic Na + channels, may importantly contribute to the anticonvulsant actions of all the drugs tested here (except topiramate); and that the significantly greater vinpocetine effect in magnitude and potency on [ 3H]Glu release when excitability is exacerbated like during seizures, may involve the increase additionally exerted by vinpocetine in some K + channels permeability.
AB - 4-Aminopyridine (4-AP) is a convulsing agent that in vivo preferentially releases Glu, the most important excitatory amino acid neurotransmitter in the brain. Here the ionic dependence of 4-AP-induced Glu release and the effects of several of the most common antiepileptic drugs (AEDs) and of the new potential AED, vinpocetine on 4-AP-induced Glu release were characterized in hippocampus isolated nerve endings pre-loaded with labelled Glu ([ 3H]Glu). 4-AP-induced [ 3H]Glu release was composed by a tetrodotoxin (TTX) sensitive and external Ca 2+ dependent fraction and a TTX insensitive fraction that was sensitive to the excitatory amino acid transporter inhibitor, TBOA. The AEDs: carbamazepine, phenytoin, lamotrigine and oxcarbazepine at the highest dose tested only reduced [ 3H]Glu release to 4-AP between 50-60%, and topiramate was ineffective. Vinpocetine at a much lower concentration than the above AEDs, abolished [ 3H]Glu release to 4-AP. We conclude that the decrease in [ 3H]Glu release linked to the direct blockade of presynaptic Na + channels, may importantly contribute to the anticonvulsant actions of all the drugs tested here (except topiramate); and that the significantly greater vinpocetine effect in magnitude and potency on [ 3H]Glu release when excitability is exacerbated like during seizures, may involve the increase additionally exerted by vinpocetine in some K + channels permeability.
KW - Carbamazepine
KW - Lamotrigine
KW - Oxcarbazepine
KW - Phenytoin
KW - Tetrodotoxin
KW - Topiramate
UR - http://www.scopus.com/inward/record.url?scp=80053917195&partnerID=8YFLogxK
U2 - 10.1016/j.eplepsyres.2011.06.006
DO - 10.1016/j.eplepsyres.2011.06.006
M3 - Journal article
C2 - 21737246
AN - SCOPUS:80053917195
VL - 96
SP - 257
EP - 266
JO - Journal of Epilepsy
JF - Journal of Epilepsy
SN - 0920-1211
IS - 3
ER -
ID: 346539061